资源描述:
《降压饮对老年高血压病(1、2级)内皮素水平的影响及降压疗效观察》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、提要目的:通过观察治疗前后血压及内皮四项值的变化,探讨内皮素在老年高血压病中的发病机制,观察降压饮临床疗效,为临床应用提供理论依据。方法:选取符合标准的60例老年高血压患者随机分为2组,治疗组30例,对照组30例。治疗组给予降压饮口服联合西药缬沙坦降压,对照组给予单药缬沙坦降压治疗。疗程8周。观察用药前后患者血压、内皮四项及症候积分的变化。结果:治疗组显效12例,有效14例,无效4例,总有效率87%。对照组显效8例,有效14例,无效8例,总有效率73%,组间比较有显著性差异(P<0.05)。两组血压治疗前后有显著性
2、差异(P<0.01),组间比较有显著性差异(P<0.01)。治疗组症候改善总有效率90.0%,对照组总有效率为66.7%,组间比较有显著性差异(P<0.05)。ET-1、PGF1a、TXB2、NO治疗前后两组有显著差异(P<0.01),组间比较有显著性差异(P<0.05)。结论:降压饮能明显降低老年高血压患者血压,改善临床症状及内皮素等血管活性物质代谢,保护血管内皮。关键词降压饮;老年高血压;内皮素;疗效观察。JiangYaYinofendothelinlevelsandantihypertensiveeffect
3、sobservedinelderlyhypertensivepatients(leveloneandtwo)Speciality:Geriatrics,internalmedicineofTCMAuthor:SuiCunsenTutor:LiRuiAbstractObjective:Toobservebloodpressureandfourendothelinchangesbeforeandaftertreatment,investigatesendothelininelderlypatientswithhyper
4、tensioninthepathogenesisandobservetheclinicalefficacyofJiangYaYintoprovideatheoreticalbasisforclinicalapplication.Method:Selected60casesofelderlypatientswithhypertensionwererandomlydividedinto2groups,treatmentgroupof30cases,controlgroupof30cases.Treatmentgroup
5、wasgiventheJiangYaYinorallycombinedwithWesternmedicineValsartanof8weeks,thecontrolgroupreceivedsingle-drugValsartantreatmentof8weeks.Toobservedbeforeandaftertreatmentthepatient'sbloodpressure,fourendothelinandthesyndromescoreofchange.Results:Thetreatmentgrouph
6、ave12markedlycases,14effectivecases,4invalidcases,thetotalefficiencyof87%.Thecontrolgrouphave8markedlycases,14effectivecases,8invalidcases,thetotalefficiencyof73%,andbetweenthetwogroupshavesignificantdifference(P<0.05).Bloodpressureofthetwogroupshavesignifican
7、tdifferencebeforeandaftertreatment(P<0.01),andbetweenthetwogroupshavesignificantdifference(P<0.01).Totalefficiencyofsymptomimproveinthetreatmentgroupis90.0%,thecontrolgroupis66.7%,andbetweenthetwogroupshavesignificantdifference(P<0.05).Beforeandaftertreatmento
8、ftheET-1,PGF1a,TXB2andNO,thetwogroupshavesignificantdifferences(P<0.01),andbetweenthetwogroupshavesignificantdifference(P<0.05).Conclusion:TheJiangYaYincansignificantlylowerbloodpr